| Question 1: Which of the following was NOT a predecessor of IROC |
| Reference: | https://fundedresearch.cancer.gov/nciportfolio/search/details;jsessionid=AE4522A922DCC1A8426CB4D7331CD0E4?action=abstract&grantNum=5U24CA180803-04&grantID=9240602&grtSCDC=FY%202017&absID=9240602&absSCDC=PUB2017 |
| Choice A: | QARC |
| Choice B: | RPC |
| Choice C: | ITC |
| Choice D: | QIBA |
| Question 2: Which of the following advanced imaging tools are being used in NCI multicenter clinical trials? |
| Reference: | Clinicaltrials.gov |
| Choice A: | DW-MRI |
| Choice B: | FES-PET |
| Choice C: | DSC-MRI |
| Choice D: | All of the above |
| Question 3: How personalized, dosimetry-based treatment planning affected median survival of hepatocellular carcinoma patients treated with Y-90 microspheres in the recent DOSISPHERE-01 trial? |
| Reference: | Garin et al. Lancet Gastroenterol Hepatol 2021 |
| Choice A: | No significant effect |
| Choice B: | 6-month improvement |
| Choice C: | 16-month improvement |
| Choice D: | 26-month improvement |
| Question 4: A future platform emulating MIDRC can deliver AI-ready imaging/clinical data: |
| Reference: | 1. A Roadmap for Foundational Research on Artificial Intelligence in Medical Imaging. From the 2018 NIH/RSNA/ACR/The Academy Workshop. Langlotz CP, Allen B, Erickson BJ, et al., Radiology 2019; 291;781-791. https://doi.org/10.1148/radiol.2019190613
A Roadmap for Translational Research on Artificial Intelligence in Medical Imaging. From the 2018 NIH/RSNA/ACR/The Academy Workshop. Allen B, Seltzer SE, Langlotz CP, et al. Journal of The American College of Radiology 2019; 16:1179-1189. |
| Choice A: | Only for (acute & long) COVID-19. |
| Choice B: | Only for chest manifestations of COVID-19 or other diseases. |
| Choice C: | Only for chest X-rays and pulmonary CT scans. |
| Choice D: | For any organ, disease, or imaging modality |
| Question 5: The guidelines from the center for innovation for radiation oncology on radiotherapy and associated imaging are created by |
| Reference: | https://www.nrgoncology.org/About-Us/Center-for-Innovation-in-Radiation-Oncology |
| Choice A: | Physicians |
| Choice B: | Physicists |
| Choice C: | Clinical trialists |
| Choice D: | All of the above |
| Question 6: Implementing adaptive radiation therapy (ART) into clinical trials should include rigorous benchmarking and/or credentialing of which of the following? |
| Reference: | Glide-Hurst, C. K., Lee, P., Yock, A. D., Olsen, J. R., Cao, M., Siddiqui, F., ... & Wuthrick, E. (2021). Adaptive radiation therapy (ART) strategies and technical considerations: a state of the ART review from NRG oncology. International Journal of Radiation Oncology* Biology* Physics, 109(4), 1054-1075. |
| Choice A: | Deformable image registration |
| Choice B: | Contouring |
| Choice C: | ART Workflow |
| Choice D: | All of the above. |
